GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is a leading pharmaceutical company in India that develops, manufactures, and markets a range of pharmaceutical products for various therapeutic areas. The company has a strong presence in India and a significant global footprint, with operations in more than 150 countries.
In terms of earnings, Revenue from Operations for Q3 FY23 was ₹802.3 crore, a 1.7% decrease from ₹815.92 crore in the same period last year. The Other Income, generated a total of ₹23.42 Crore to Total Revenue which jumped by 127% from the previous year same quarter.
A total of ₹153 Crore were contributed by the Employee Benefit Expense to the Total Expense, an increased of 7.4% from the same quarter last year. The Consolidated Net Profit was ₹164.56 crore, up 9.4% from ₹150.35 crore in the same quarter last year. This quarter’s earnings per share was ₹9.71.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,